Bayer Aktiengesellschaft is a German multinational pharmaceutical and life sciences company with a market capitalization of 59 billion euros. According to the data provided, the current market cap of the company has decreased from 5 February 2023 (55.8 bln euro) to 3 February 2023 (55.7 bln euro). This decrease corresponds to 0.5293% or 297 mln euros in one day.
The company’s price-earnings ratio is 12.58 which is lower than the industry average of 19 indicating that investors are not overly keen on buying Bayer Aktiengesellschaft’s shares at present levels even though its earnings per share stands strong at 4.78 euro as of 3 February 2023. The 200-day simple moving average for Bayer Aktiengesellschaft stood at 55 euro while its 50-day simple moving average was 53.81 euro as of 3 February 2023. The year low for Bayer Aktiengesellschaft was 46.7 on 6 April 2020 while its year high was 67.99 on 7 January 2021 signifying a volatile financial performance over the past year and making it difficult to predict further stock prices movements accurately in short term investments horizon due to macroeconomic outlook risks associated with pandemic situation and government policy changes in healthcare sector which may have an impact on future cash flows generating potentials of this company if they materialize in near future..
